Change in volumetric tumor growth rate after cytotoxic therapy is predictive of overall survival in recurrent glioblastoma.
Neurooncol Adv
; 5(1): vdad084, 2023.
Article
in En
| MEDLINE
| ID: mdl-37554221
Full text:
1
Database:
MEDLINE
Type of study:
Prognostic_studies
/
Risk_factors_studies
Language:
En
Year:
2023
Type:
Article